Absci (ABSI) and Owkin announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for ...

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...

A recent class action lawsuit against ASML Holding N.V. underscores significant developments in the AI chips sector, focusing ...

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer.

Palantir, Netflix and three high-flying "apps" maintain their spot among 25 highly rated stocks in the top-ranked industries.

Crypto ETFs rallied as Bitcoin hit a $108,000 milestone in December but have fallen with the digital asset in 2025.

Francis deSouza is Google Cloud’s new chief operating officer. He co-founded AI research startup Synth Labs last year after ...

About 5,000 frontline health professionals at Providence Health & Services are slated to walk off the job starting 6 a.m.

Churchill Downs Incorporated ("CDI” or "the Company”) announced today that the Company will release fourth quarter and full year 2024 financial results after the market closes on Wednesday, February ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

Real estate giant Dar Global said it plans to expand in the U.S. and Greece after the Dubai-based developer recently unveiled projects in partnership with the Trump Organization, Reuters reported ...